Comment on: Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comment on: Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients

Published:2024-05-09 Issue:7 Volume:79 Page:1717-1718
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Chen I Wen¹,Chang Li-Chen²,Hung Kuo-Chuan³

Affiliation:

1. Department of Anesthesiology, Chi Mei Medical Center, Liouying , Tainan City , Taiwan

2. Department of Anesthesiology, E-Da Hospital, I-Shou University , Kaohsiung City , Taiwan

3. Department of Anesthesiology, Chi Mei Medical Center , No.901, ChungHwa Road, YungKung Dist, Tainan City 71004 , Taiwan

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/jac/article-pdf/79/7/1717/58375173/dkae124.pdf

Reference3 articles.

1. Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients;Sun;J Antimicrob Chemother,2023

2. Trial sequential analysis: novel approach for meta-analysis;Kang;Anesth Pain Med (Seoul),2021

3. Trial sequential analysis in systematic reviews with meta-analysis;Wetterslev;BMC Med Res Methodol,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP